Dr Lee highlights the latest treatment developments in non–clear cell renal cell carcinoma, emphasizes the need for more precise classification of the histologic subsets of this disease, and discusses the investigation of cabozantinib plus nivolumab across stratified cohorts of non–clear cell renal cell carcinoma.

S7 Ep6: Lee Lays Out Treatment Developments in Non–Clear Cell RCC

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

Share S7 Ep6: Lee Lays Out Treatment Developments in Non–Clear Cell RCC

Sign up to save your podcasts

S7 Ep6: Lee Lays Out Treatment Developments in Non–Clear Cell RCC

S7 Ep6: Lee Lays Out Treatment Developments in Non–Clear Cell RCC

More shows like OncLive® On Air

Wait Wait... Don't Tell Me!

Marketplace Morning Report

Marketplace

Research To Practice | Oncology Videos

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

JAMA Clinical Reviews

ASCO Daily News

The Curbsiders Internal Medicine Podcast

OncoPharm

ASCO Guidelines

Lung Cancer Considered

Oncology Today with Dr Neil Love

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions

NEJM AI Grand Rounds